Apolizumab videos and info

Diemazz

mib 3 read only
t924t
68 AH
Hormones
Waddy Young
Gini coefficient
Fillmore Western Railway
Stringed instrument tunings
Keretapi Tanah Melayu
t864t
0732911885
Flying Fox of Snowy Mountain
Harry Mason
t104t
William Butterworth Bayley
A Step Into The Past
Imanol Uribe
Image:Matzo jpg
t435t
Alfonso III of Le
christie s room
Image:SiennaMillerFactoryGirl jpg
WZZS
Destination hotel
Four Days Battle
1980 in music
VPN
Bahnar people
Mount Poso Oil Field
Telemundo
Morlanwelz
Solid state lighting
True Move
Bishop of Horsham
Image:Culture show jpg
Thomas Sigismund Stribling
andrew w mellon foundation
indosatm2 service providers
Intermediary corporation
The Smiths
Template:BCYearInTopic
sand dollar auto

Apolizumab^?

Therapeutic monoclonal antibody

Source Human

Target 1D10

Identifiers

CAS number ?

ATC code ?

PubChem ?

Chemical data

Formula ?

Mol. mass ?

Pharmacokinetic data

Bioavailability ?

Metabolism ?

Half life ?

Excretion ?

Therapeutic considerations

Pregnancy cat.
?

Legal status

Routes ?

Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.^[1]

References

^ Bayes M, Rabasseda X, Prous J (2003). "Gateways to clinical trials.". Methods Find Exp Clin Pharmacol 25 (9): 747–71. PMID 14685303.

v • d • e Humanized monoclonal antibodies ("-zu-")

"-tuzu-" (tumor)	Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan, Clivatuzumab tetraxetan, Dacetuzumab, Elotuzumab^†, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab^†, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan*, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab

"-lizu-" (immune system)	immunosuppressive: Aselizumab, Atlizumab, Apolizumab, Cedelizumab, Certolizumab pegol, Daclizumab, Eculizumab, Efalizumab, Epratuzumab, Erlizumab, Fontolizumab, Lebrilizumab, Mepolizumab, Natalizumab, Ocrelizumab, Omalizumab, Pascolizumab, Pexelizumab, Reslizumab, Rintalizumab, Rovelizumab, Ruplizumab, Siplizumab, Talizumab, Teplizumab, Tocilizumab, Toralizumab, Vedolizumab, Visilizumab, TGN1412 non-immunosuppressive:* Ibalizumab^†

"-bazu-" (bacterial)	Tefibazumab^†

"-cizu-" (cardiovascular)	Alacizumab pegol, Bevacizumab, Sonepcizumab, Tadocizumab

"-nezu-"/"-neuzu-" (nervous system)	Bapineuzumab, Stolanezumab*, Tanezumab

"-toxazu-" (toxin as target)	Urtoxazumab

"-vizu-" (viral infections)	Felvizumab, Motavizumab, Palivizumab, PRO 140^†

"-kinzu-" (interleukin as target)	Anrukinzumab, Drimakinzumab, Ginakinzumab, Vimakinzumab, Vontakinzumab

*Names under consideration by the USAN Council. ^†Undergoing clinical trials.

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wikipedia.org/wiki/Apolizumab"

Categories: Monoclonal antibodies | Monoclonal antibody stubs

Site Map: RSS 2.0

Recent Searches: Apolizumab
Common year starting on Wednesday
Image:Memory module DDRAM 20 03 2006 jpg
1048
Image:SiennaMillerFactoryGirl jpg
Religion in China
NTV
Mount Poso Oil Field
Bloody Roar (video game)
Thomas Sigismund Stribling